| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |